MLTX Long Call Strategy
MLTX (MoonLake Immunotherapeutics), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
MLTX (MoonLake Immunotherapeutics) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.36B, a beta of 1.01 versus the broader market, a 52-week range of 5.95-62.75, average daily share volume of 1.2M, a public-listing history dating back to 2020, approximately 100 full-time employees. These structural characteristics shape how MLTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.01 places MLTX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long call on MLTX?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current MLTX snapshot
As of May 15, 2026, spot at $17.54, ATM IV 74.60%, IV rank 18.27%, expected move 21.39%. The long call on MLTX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on MLTX specifically: MLTX IV at 74.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a MLTX long call, with a market-implied 1-standard-deviation move of approximately 21.39% (roughly $3.75 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MLTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on MLTX should anchor to the underlying notional of $17.54 per share and to the trader's directional view on MLTX stock.
MLTX long call setup
The MLTX long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MLTX near $17.54, the first option leg uses a $18.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MLTX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MLTX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $18.00 | $1.50 |
MLTX long call risk and reward
- Net Premium / Debit
- -$150.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$150.00
- Breakeven(s)
- $19.50
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
MLTX long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on MLTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | -$150.00 |
| $3.89 | -77.8% | -$150.00 |
| $7.76 | -55.7% | -$150.00 |
| $11.64 | -33.6% | -$150.00 |
| $15.52 | -11.5% | -$150.00 |
| $19.40 | +10.6% | -$10.46 |
| $23.27 | +32.7% | +$377.25 |
| $27.15 | +54.8% | +$764.96 |
| $31.03 | +76.9% | +$1,152.67 |
| $34.90 | +99.0% | +$1,540.38 |
When traders use long call on MLTX
Long calls on MLTX express a bullish thesis with defined risk; traders use them ahead of MLTX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
MLTX thesis for this long call
The market-implied 1-standard-deviation range for MLTX extends from approximately $13.79 on the downside to $21.29 on the upside. A MLTX long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current MLTX IV rank near 18.27% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MLTX at 74.60%. As a Healthcare name, MLTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MLTX-specific events.
MLTX long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MLTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MLTX alongside the broader basket even when MLTX-specific fundamentals are unchanged. Long-premium structures like a long call on MLTX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current MLTX chain quotes before placing a trade.
Frequently asked questions
- What is a long call on MLTX?
- A long call on MLTX is the long call strategy applied to MLTX (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With MLTX stock trading near $17.54, the strikes shown on this page are snapped to the nearest listed MLTX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MLTX long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the MLTX long call priced from the end-of-day chain at a 30-day expiry (ATM IV 74.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$150.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MLTX long call?
- The breakeven for the MLTX long call priced on this page is roughly $19.50 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MLTX market-implied 1-standard-deviation expected move is approximately 21.39%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on MLTX?
- Long calls on MLTX express a bullish thesis with defined risk; traders use them ahead of MLTX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current MLTX implied volatility affect this long call?
- MLTX ATM IV is at 74.60% with IV rank near 18.27%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.